Companies
Avalo Therapeutics Inc [AVTX] Revenue clocked in at $1.93 million, up 139.01% YTD: What’s Next?
Avalo Therapeutics Inc [NASDAQ: AVTX] price surged by 357.89 percent to reach at $17.0. The company report on March 29, 2024 at 4:01 PM that Avalo Reports 2023 Financial Results and Provides Business Updates. Acquired AVTX-009, Phase-2 ready anti-IL-1β mAb, in March 2024. Increased cash
